Tag : clinical research

Clinical Research, Pharma & Healthcare Financing

Egret Therapeutics Signs MOU with Genexine for PD-1 Asset

PR Newswire
by PR Newswire036
Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation following acute injury Egret Therapeutics, Inc....
Clinical Research, Pharma & Healthcare Financing

Outrun Therapeutics Launches HPV+ Head & Neck Cancer Program

PR Newswire
by PR Newswire041
Outrun Therapeutics (“Outrun” or “the Company”), a biotech developing protein stabilising therapeutics identified by its proprietary XL discovery platform, today announces the selection of its...
Clinical Research, Pharma & Healthcare Financing

KERENDIA® Meets Phase III Primary Endpoint in CKD Study

Business Wire
by Business Wire041
KERENDIA® (finerenone) met its primary endpoint demonstrating a statistically significant improvement vs. placebo in the estimated glomerular filtration rate (eGFR) slope from baseline to Month 32...
Clinical Research, Pharma & Healthcare Financing

RevnaBio Earns Triple Lab Accreditation in Africa

Business Wire
by Business Wire033
A2LA accreditation across ISO 15189, ISO 20387, and ISO/IEC 17043 strengthens diagnostic quality for patients while enabling global pharmaceutical and research partnerships. RevnaBio today announced...
Clinical Research, Pharma & Healthcare Financing

WuXi Biologics Wins Multiple Asia-Pacific Biopharma Awards

PR Newswire
by PR Newswire050
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two...
Clinical Research, Pharma & Healthcare Financing

NervGen Pharma Voluntarily Delists from TSX Venture

GlobeNewswire
by GlobeNewswire048
NervGen Pharma Corp. (“NervGen” or the “Company”) (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and...
Clinical Research, Pharma & Healthcare Financing

Combat Medical Raises £2.6M for Bladder Cancer Treatment

Business Wire
by Business Wire046
Combat Medical (Combat), a medical device company optimising the delivery and efficacy of cancer therapeutics, today announced it has raised £2.6 million in the first...
Clinical Research, Pharma & Healthcare Financing

Personalis Study Advances Breast Cancer Treatment Monitoring

Business Wire
by Business Wire046
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of the PREDICT-DNA study in the Journal of Clinical Oncology....
Clinical Research, Pharma & Healthcare Financing

Meiji Seika Starts Phase I Trial for ME3241 in Australia

Business Wire
by Business Wire046
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced today that it has initiated a Phase I clinical...
Clinical Research, Pharma & Healthcare Financing

GenomOncology Partners with WeTrials to Speed CNS Trials

PR Newswire
by PR Newswire051
GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and trial enablement platform, to help CNS...
Clinical Research, Pharma & Healthcare Financing

ARTHEx Biotech Gets FDA Fast Track for ATX-01 in DM1

PR Newswire
by PR Newswire045
ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast...
Clinical Research, Pharma & Healthcare Financing

QuantHealth Reports 8x Growth in Life Sciences Engagements

Business Wire
by Business Wire068
The Company Has Established the Industry’s Most Advanced Portfolio of Clinical Trial Simulation Capabilities for Pharmaceutical and Biotechnology Companies QuantHealth, a pioneer in AI-driven clinical...
Clinical Research, Pharma & Healthcare Financing

C-Further Unveils First Pediatric Oncology Therapeutics

Business Wire
by Business Wire069
C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple...
Clinical Research, Pharma & Healthcare Financing

Alzheon to Present ALZ-801 Trial Results at 2026 AD/PD

Business Wire
by Business Wire049
Alzheon Reports Valiltramiprosate Shows Promise as an Oral Potentially Disease-Modifying Agent to Slow Alzheimer’s Disease Based on Clinical, MRI, and Biomarker Data in APOE4/4 MCI...
Clinical Research, Pharma & Healthcare Financing

Belite Bio Reports Preliminary FY2025 Financial Results

GlobeNewswire
by GlobeNewswire043
Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that...